Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

NCT03249103 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aptinyx

Collaborators